ScopeThe report provides information on the key drivers and challenges of the Hepatitis A Preventive Vaccines market. Its Scope includes -
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Hepatitis A Preventive Vaccines market revenues data from 2005 to 2010, forecast for seven years to 2017.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates are very few in number and are majorly product extension of an already approved vaccines. They fall under major vaccine class inactivated vaccine. Analysis of the current and future competition in the seven key countries Hepatitis A Preventive Vaccines market. Key market players covered are Merck and Co., GlaxoSmithKline, Sanofi Pasteur MSD and Variation Biotechnologies.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Hepatitis A Preventive Vaccines therapeutics market.
Reasons to buyThe report will enhance your decision making capability. It will allow you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Hepatitis A Preventive Vaccines market.
- Drive revenues by understanding t
Copyright©2010 PR Newswire.
All rights reserved